WASHINGTON, Nov. 12 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Taizhou Kangping Medical Science and Technology Co. Ltd. from the Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Yuegen Wang, General Manager, Taizhou Kangping Medical Science and Technology Co., Ltd., Building 3, No 27 Tai'an Road, Hailing Industrial Park, Hailing Qu Taizhou Shi Jiangsu Sheng, 225300, China